|
Name |
12-Deacetylphomoxanthone
|
Molecular Formula | C36H36O15 | |
IUPAC Name* |
[(3S,4S,4aS)-5-[(5S,6S,10aS)-5-acetyloxy-1,9-dihydroxy-10a-(hydroxymethyl)-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-4-yl]-4-acetyloxy-8,9-dihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthen-4a-yl]methyl acetate
|
|
SMILES |
C[C@H]1CC(=O)C2=C(C3=C(C=CC(=C3O[C@]2([C@H]1OC(=O)C)CO)C4=C5C(=C(C=C4)O)C(=C6C(=O)C[C@@H]([C@@H]([C@@]6(O5)COC(=O)C)OC(=O)C)C)O)O)O
|
|
InChI |
InChI=1S/C36H36O15/c1-14-10-23(43)27-29(45)25-21(41)8-6-19(31(25)50-35(27,12-37)33(14)48-17(4)39)20-7-9-22(42)26-30(46)28-24(44)11-15(2)34(49-18(5)40)36(28,51-32(20)26)13-47-16(3)38/h6-9,14-15,33-34,37,41-42,45-46H,10-13H2,1-5H3/t14-,15-,33-,34-,35+,36+/m0/s1
|
|
InChIKey |
CJMACRHPNHADNA-PGQKKIPJSA-N
|
|
Synonyms |
12-deacetylphomoxanthone
|
|
CAS | NA | |
PubChem CID | 73293507 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 708.7 | ALogp: | 2.2 |
HBD: | 5 | HBA: | 15 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 233.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 51 | QED Weighted: | 0.211 |
Caco-2 Permeability: | -5.465 | MDCK Permeability: | 0.00003590 |
Pgp-inhibitor: | 0.633 | Pgp-substrate: | 0.984 |
Human Intestinal Absorption (HIA): | 0.365 | 20% Bioavailability (F20%): | 0.198 |
30% Bioavailability (F30%): | 0.421 |
Blood-Brain-Barrier Penetration (BBB): | 0.021 | Plasma Protein Binding (PPB): | 81.83% |
Volume Distribution (VD): | 0.536 | Fu: | 20.82% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.046 |
CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.08 |
CYP2D6-inhibitor: | 0.062 | CYP2D6-substrate: | 0.077 |
CYP3A4-inhibitor: | 0.784 | CYP3A4-substrate: | 0.245 |
Clearance (CL): | 1.231 | Half-life (T1/2): | 0.017 |
hERG Blockers: | 0.023 | Human Hepatotoxicity (H-HT): | 0.786 |
Drug-inuced Liver Injury (DILI): | 0.962 | AMES Toxicity: | 0.027 |
Rat Oral Acute Toxicity: | 0.989 | Maximum Recommended Daily Dose: | 0.159 |
Skin Sensitization: | 0.189 | Carcinogencity: | 0.196 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.294 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002870 | 0.890 | D0Q0PR | 0.266 | ||||
ENC001968 | 0.881 | D0T5XN | 0.256 | ||||
ENC005074 | 0.816 | D0FX2Q | 0.255 | ||||
ENC001973 | 0.792 | D07IPB | 0.255 | ||||
ENC001969 | 0.786 | D0OL7F | 0.253 | ||||
ENC005075 | 0.721 | D08FPM | 0.251 | ||||
ENC002105 | 0.701 | D07VLY | 0.245 | ||||
ENC001991 | 0.686 | D0C9XJ | 0.245 | ||||
ENC003646 | 0.630 | D02GAC | 0.243 | ||||
ENC005073 | 0.622 | D08LTU | 0.243 |